Skip to content

Amgen

US · AMGN #59 by market cap Listed 1970 Quant Rating C 67
437.23 -6.89 -1.55%
Collector offline (last heartbeat: 19205s ago) · 2026-09-04 19:59
Pre-market 438.95 -1.16%
After-hours 415.00 -5.08%
Overnight 442.22 -0.43%
Market cap
236.38B
P/B
20.22
EPS
14.23

Recent news

  • Amgen Advances Tarlatamab Shot Vs. Infusion in Phase 3 Lung Cancer Study
    TipRanks · 8/22
  • Amgen | 3: Initial statement of beneficial ownership of securities- Dittrich Thomas J.W.
    SEC · 9/5
  • Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Busch Matthew C.
    SEC · 5/12
  • Truist Financial Maintains Amgen(AMGN.US) With Hold Rating
    Market Newswire · 8/28
  • Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $457
    Market Newswire · 8/20
  • Scotiabank Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $450
    Market Newswire · 8/28
  • Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Grygiel Nancy A.
    SEC · 5/12
  • William Blair Maintains Amgen(AMGN.US) With Buy Rating
    Market Newswire · 8/27
  • Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Grygiel Nancy A.
    SEC · 8/8
  • Amgen | 4: Statement of changes in beneficial ownership of securities-Director Klotman Mary E.
    SEC · 5/22
  • TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $452
    Market Newswire · 8/27
  • Amgen | 4: Statement of changes in beneficial ownership of securities-Director Garland Greg C.
    SEC · 5/22

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-09-04 19:59:10

For reference only, not investment advice.